We are proud to announce the establishment of an academic collaboration with the Bordeaux Laboratory of Galenic Pharmacy and Biopharmacy, member of the Institute of Mechanics and Engineering - I2M, UMR CNRS 5295.
Last week, Skyepharma contributed to the Compaction Simulation Forum.
Skyepharma’s Analytical Development department recently acquired a BET Analyzer, used for Surface area and Pore Size Analysis. With this new tool, Skyepharma’s dedicated Analytical team is able to study the porous structure of raw materials which impacts the final product properties, such as the dissolution profile, shelf life and bioavailability.
David LESCUYER – EVP Oral Business, Vectura Group of Companies – President of SKYEPHARMA PRODUCTION SAS:
“With over 20 years of experience in complex oral solid dosage forms, we help our customers on reformulation, Life Cycle Management, trouble shooting, scale up and technical transfer of their products.
February 7, 2018 -
4.1 million Investment results in upgrade to SKYEPHARMA Development & Manufacturing site in Lyon. Acquisition of a new Marchesini bottling line will improve capacity and capabilies from March 2018.